From the United Nations procurement to explore the hot spot of the international public market - "soft" standards will become one of the thresholds for Chinese pharmaceutical companies to go to sea on January 02, 2024
Au Development Agency - NEPAD invites companies to participate in drug review pilot 07 November 2023
[Press Release] : Webinar Update of FDA's Breakthrough Medical Device Program Final Guidelines October 12, 2023
FDA International Standard ISO 10993-1 (Biocompatibility) Final Guidelines Seminar September 08, 2023
What are the new features of global pharmaceutical and health industrial policy initiatives? April 8th, 2022
$29.1 billion! Us Digital Health Market 2021 This year January 14, 2022
18 innovative treatments to be approved by FDA! January 14, 2022
$20.7 billion! Novartis divested Roche on November 05, 2021
Leapfrog WHO-PQ certification of domestically produced COVID-19 vaccines guarantees vaccine supply to developing countries 25 October 2021
Major progress in cervical cancer! FDA approves Merck's Keytruda+ platinum-based chemotherapy: the first first-line anti-PD-1 combination therapy. October 18, 2021
2021H1 Global RNA Therapy Investment Report: 28 financing, 1/3 in China; New technologies are emerging and pharmaceutical giants are scrambling to enter the market August 13, 2021
About Us! Contact Us! Member's Home! Industry Service
Address: 11-12 Floor, No.6 Nanzhujia Hutong, Chaoyang Mennei Street, Dongcheng District, Beijing (Beijing INN Building No. 3)
Copyright: China Chamber of Commerce for Import and Export of Medicine and Health Products. All rights reserved
Beijing ICP: 06034461-1 Beijing public network security 11010102002916
Internet drug information service Qualification Certificate number: (Beijing) - non-operational -2020-0090